These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 24627317)
1. In arterial occlusive disease autoantibodies against ETAR and AT(1)R correlate with each other but are not associated with classical cardiovascular risk factors. Albert C; von Schultzendorff M; Şalaru D; Halloul Z; Dragun D; Heidecke H; Mertens PR Vasa; 2014 Mar; 43(2):113-23. PubMed ID: 24627317 [TBL] [Abstract][Full Text] [Related]
2. Serum levels for midkine, a heparin-binding growth factor, inversely correlate with angiotensin and endothelin receptor autoantibody titers in patients with macroangiopathy. Salaru DL; Albert C; Königsmark U; Brandt S; Halloul Z; Heller A; Heidecke H; Dragun D; Mertens PR Int Angiol; 2014 Aug; 33(4):372-8. PubMed ID: 25056169 [TBL] [Abstract][Full Text] [Related]
3. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis. Budding K; van de Graaf EA; Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Dragun D; Hack CE; Otten HG J Cyst Fibros; 2015 Jan; 14(1):42-5. PubMed ID: 25096855 [TBL] [Abstract][Full Text] [Related]
4. Autoantibodies and biomarkers of endothelial cell activation in atherosclerosis. López-Mejías R; Genre F; González-Juanatey C; González-Gay MA Vasa; 2014 Mar; 43(2):83-5. PubMed ID: 24627313 [No Abstract] [Full Text] [Related]
5. Non-HLA Autoantibodies at 1 Year Negatively Affect 5-Year Native Renal Function in Liver Transplant Recipients. O'Leary JG; Philippe A; Freeman R; Heidecke H; Jennings LW; Catar R; Klintmalm GB; Dragun D Transplant Proc; 2021 Apr; 53(3):1019-1024. PubMed ID: 33579550 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients. Günther J; Kill A; Becker MO; Heidecke H; Rademacher J; Siegert E; Radić M; Burmester GR; Dragun D; Riemekasten G Arthritis Res Ther; 2014 Mar; 16(2):R65. PubMed ID: 24612997 [TBL] [Abstract][Full Text] [Related]
7. Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course. Miedema J; Schreurs M; van der Sar-van der Brugge S; Paats M; Baart S; Bakker M; Hoek R; Dik WA; Endeman H; Van Der Velden V; van Gammeren A; Ermens A; Aerts JG; Thüsen JV Front Immunol; 2021; 12():684142. PubMed ID: 34054876 [TBL] [Abstract][Full Text] [Related]
8. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis. Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620 [TBL] [Abstract][Full Text] [Related]
9. Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA. Bankamp L; Preuß B; Pecher AC; Beucke N; Henes J; Klein R Front Immunol; 2021; 12():786039. PubMed ID: 34956217 [TBL] [Abstract][Full Text] [Related]
10. The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes. Banasik M; Boratyńska M; Kościelska-Kasprzak K; Krajewska M; Mazanowska O; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Nowakowska B; Hałoń A; Dawiskiba T; Chudoba P; Klinger M Transpl Immunol; 2014 Jan; 30(1):24-9. PubMed ID: 24184747 [TBL] [Abstract][Full Text] [Related]
11. Antibodies against angiotensin II receptor type 1 and endothelin A receptor are increased in COVID-19 patients. Miedema JR; Janssen ML; von der Thüsen J; Endeman H; Langerak AW; Hellemons ME; van Nood E; Peeters BWA; Baart SJ; Schreurs MWJ Front Immunol; 2023; 14():1204433. PubMed ID: 37622126 [TBL] [Abstract][Full Text] [Related]
12. Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies. Civieri G; Iop L; Tona F Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055116 [TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against Endothelin 1 Type A Receptor Are Strong Predictors of Digital Ulcers in Systemic Sclerosis. Avouac J; Riemekasten G; Meune C; Ruiz B; Kahan A; Allanore Y J Rheumatol; 2015 Oct; 42(10):1801-7. PubMed ID: 26233500 [TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis. Kill A; Tabeling C; Undeutsch R; Kühl AA; Günther J; Radic M; Becker MO; Heidecke H; Worm M; Witzenrath M; Burmester GR; Dragun D; Riemekasten G Arthritis Res Ther; 2014 Jan; 16(1):R29. PubMed ID: 24472528 [TBL] [Abstract][Full Text] [Related]
15. Non-HLA antibodies in solid organ transplantation: recent concepts and clinical relevance. Dragun D; Catar R; Philippe A Curr Opin Organ Transplant; 2013 Aug; 18(4):430-5. PubMed ID: 23838648 [TBL] [Abstract][Full Text] [Related]
17. Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension. Guo L; Li M; Chen Y; Wang Q; Tian Z; Pan S; Zeng X; Ye S Arthritis Rheumatol; 2015 Sep; 67(9):2394-402. PubMed ID: 26018988 [TBL] [Abstract][Full Text] [Related]
18. Functional autoantibodies against Endothelin-1 receptor type A and Angiotensin II receptor type 1 in patients with preeclampsia. Buttrup Larsen S; Wallukat G; Schimke I; Sandager A; Tvilum Christensen T; Uldbjerg N; Tørring N Pregnancy Hypertens; 2018 Oct; 14():189-194. PubMed ID: 30527110 [TBL] [Abstract][Full Text] [Related]
19. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Riemekasten G; Philippe A; Näther M; Slowinski T; Müller DN; Heidecke H; Matucci-Cerinic M; Czirják L; Lukitsch I; Becker M; Kill A; van Laar JM; Catar R; Luft FC; Burmester GR; Hegner B; Dragun D Ann Rheum Dis; 2011 Mar; 70(3):530-6. PubMed ID: 21081526 [TBL] [Abstract][Full Text] [Related]
20. Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score. Che J; Li G; Wang W; Li Q; Liu H; Chen K; Liu T Cardiol J; 2011; 18(4):364-70. PubMed ID: 21769816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]